Boston Hemophilia Center

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

The Boston Hemophilia Center is the largest hemophilia program in New England. As a federally-funded hemophilia treatment center (HTC) and joint program with Brigham and Women's Hospital, we provide comprehensive care to children and adults with hemophilia and other bleeding disorders. At Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, we care for infants, children, adolescents and young adults. Adult patients are treated at Brigham and Women's Hospital and are seen for outpatient visits at the Yawkey Center at Dana-Farber Cancer Institute.

Boston Hemophilia Center services include: 

  • Comprehensive medical evaluation and treatment
  • Clinic visits focused on education and individualized care to help you effectively manage your child’s disease
  • Evaluation of bleeding episodes, which includes:
    • giving medical orders to home care nurses who can infuse your child at home
    • identifying and determining when a clinic visit is necessary
    • identifying and determining when an emergency room visit or admission is required
    • addressing home infusion questions
  • Counseling and support, including ongoing dialogue between clinic visits by phone
  • Access to new treatment approaches through clinical research

Please note: The Boston Hemophilia Center has moved most of its web content to the Dana-Farber/Boston Children's Cancer and Blood Disorders Center website. Visit us there to find more in-depth information on the Boston Hemophilia Center, including how we diagnose and treat hemophilia, our Factor Program, our Home Infusion Program, genetic testing, family programs, our Centerpoints newsletter, research, and much more. You can also meet the Boston Hemophilia Center physicians and staff.

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Contact the Boston Hemophilia Center

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO
Close